(Updated - June 24, 2026 6:20 AM EDT)

Barclays analyst Eliana Merle initiates coverage on SAB Biotherapeutics (NASDAQ: SABS) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments New Coverage